Manufacturers Life Insurance Company, The Biomarin Pharmaceutical Inc Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 159,917 shares of BMRN stock, worth $9.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
159,917
Previous 180,617 11.46%
Holding current value
$9.95 Million
Previous $14.9 Million 24.41%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$69.02 - $93.84 $1.43 Million - $1.94 Million
-20,700 Reduced 11.46%
159,917 $11.2 Million
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $8.6 Million - $10.7 Million
115,578 Added 177.71%
180,617 $14.9 Million
Q1 2024

May 14, 2024
SELL
$83.81 - $99.0 $784,880 - $927,135
-9,365 Reduced 12.59%
65,039 $5.68 Million
Q4 2023

Feb 13, 2024
BUY
$76.22 - $98.51 $892,459 - $1.15 Million
11,709 Added 18.68%
74,404 $7.17 Million
Q3 2023

Nov 15, 2023
BUY
$85.07 - $94.48 $606,123 - $673,170
7,125 Added 12.82%
62,695 $5.55 Million
Q2 2023

Aug 11, 2023
BUY
$86.68 - $100.3 $1.44 Million - $1.67 Million
16,620 Added 42.67%
55,570 $4.82 Million
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $1.71 Million - $2.29 Million
19,510 Added 50.09%
58,460 $5.68 Million
Q4 2022

Aug 11, 2023
BUY
$80.93 - $108.63 $1.11 Million - $1.49 Million
13,689 Added 54.19%
38,950 $4.03 Million
Q4 2022

Feb 13, 2023
BUY
$80.93 - $108.63 $1.11 Million - $1.49 Million
13,689 Added 54.19%
38,950 $4.03 Million
Q3 2022

Aug 11, 2023
BUY
$82.16 - $96.94 $340,881 - $402,204
4,149 Added 19.65%
25,261 $2.14 Million
Q3 2022

Nov 03, 2022
BUY
$82.16 - $96.94 $340,881 - $402,204
4,149 Added 19.65%
25,261 $2.15 Million
Q2 2022

Aug 11, 2023
BUY
$71.48 - $86.85 $1,072 - $1,302
15 Added 0.07%
21,112 $1.75 Million
Q2 2022

Aug 15, 2022
BUY
$71.48 - $86.85 $1,072 - $1,302
15 Added 0.07%
21,112 $1.77 Million
Q1 2022

Aug 11, 2023
SELL
$74.28 - $92.69 $2.78 Million - $3.46 Million
-37,363 Reduced 63.91%
21,097 $1.63 Million
Q1 2022

May 20, 2022
BUY
$74.28 - $92.69 $1.32 Million - $1.65 Million
17,791 Added 538.14%
21,097 $1.64 Million
Q4 2021

Feb 16, 2022
SELL
$71.72 - $91.47 $32,417 - $41,344
-452 Reduced 12.03%
3,306 $292,000
Q2 2020

Aug 10, 2020
SELL
$79.55 - $124.22 $39,615 - $61,861
-498 Reduced 11.7%
3,758 $459,000
Q1 2020

May 15, 2020
SELL
$71.37 - $96.85 $17,628 - $23,921
-247 Reduced 5.49%
4,256 $360,000
Q4 2019

Feb 14, 2020
SELL
$64.27 - $86.37 $9,961 - $13,387
-155 Reduced 3.33%
4,503 $381,000
Q3 2019

Nov 12, 2019
SELL
$67.4 - $85.11 $13,817 - $17,447
-205 Reduced 4.22%
4,658 $318,000
Q2 2019

Aug 14, 2019
SELL
$80.35 - $93.9 $18,801 - $21,972
-234 Reduced 4.59%
4,863 $417,000
Q1 2019

May 13, 2019
SELL
$84.2 - $98.62 $3,789 - $4,437
-45 Reduced 0.88%
5,097 $453,000
Q4 2018

Feb 14, 2019
BUY
$80.14 - $106.07 $400 - $530
5 Added 0.1%
5,142 $438,000
Q3 2018

Nov 14, 2018
SELL
$93.92 - $105.72 $124,913 - $140,607
-1,330 Reduced 20.57%
5,137 $498,000
Q2 2018

Aug 14, 2018
SELL
$76.01 - $99.03 $5,776 - $7,526
-76 Reduced 1.16%
6,467 $609,000
Q1 2018

May 15, 2018
SELL
$77.67 - $92.63 $15,145 - $18,062
-195 Reduced 2.89%
6,543 $530,000
Q4 2017

Feb 08, 2018
SELL
$80.76 - $95.13 $39,976 - $47,089
-495 Reduced 6.84%
6,738 $600,000
Q3 2017

Nov 14, 2017
BUY
$80.6 - $94.95 $582,979 - $686,773
7,233
7,233 $673,000

Others Institutions Holding BMRN

# of Institutions
641
Shares Held
177M
Call Options Held
2M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.6B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email